EXEL
NASDAQ · Biotechnology
Exelixis Inc
$54.07
+1.87 (+3.58%)
Analyst Consensus
Hold
25
Analysts
High
Coverage
Price Target
Analyst Price Target
+114.7% upside
Low Target
$78.53
Average Target
$116.10
High Target
$123.77
Current Price
$54.07
Current
$54.07
$54.07
Target
$116.10
$116.10
$78.53
$116.10 avg
$123.77
Scenario Analysis
Bear Case
$78.53
45.2%
Low target
Base Case
$116.10
+114.7%
Avg target
Bull Case
$123.77
+128.9%
High target
Risk/Reward
2.8x
Favorable
Price in Context
52-Week High
$57.57
-6.1% from high
52-Week Low
$33.76
+60.2% from low
50-Day SMA
$43.59
+24.0% vs SMA
200-Day SMA
$41.49
+30.3% vs SMA
RSI (14)
62.0
Neutral
Target vs 52W High
$116.10
+101.7% vs high
Peer Consensus — Biotechnology
| Stock | Consensus | Analysts | Buy % | Target | Upside |
|---|---|---|---|---|---|
| ABBV | Strong Buy | 39 | 79% | $257.58 | +4.7% |
| AMGN | Hold | 43 | 49% | $190.87 | -53.6% |
| GILD | Strong Buy | 37 | 81% | $362.68 | +172.3% |
| VRTX | Strong Buy | 40 | 83% | $438.34 | -11.6% |
| REGN | Buy | 38 | 71% | $76.80 | -90.2% |
| NTRA | Strong Buy | 30 | 87% | $142.91 | -55.6% |
| RVMD | Strong Buy | 29 | 93% | $114.11 | -44.4% |
| BIIB | Buy | 44 | 64% | $91.45 | -56.0% |